Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
LENZ Therapeutics, Inc.Listing on record | Sell | $1.6M | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $8.3K | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $2.7M | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $3.9M | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $5.8K | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $2.3M | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $6.1M | SEC | ||
LENZ Therapeutics, Inc.Listing on record | Sell | $10.2M | SEC | ||
GRAPHITE CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
GRAPHITE CORPListing unverified | Buy | $3.1M | conv 46ClusterFirst in 12mo | SEC | |
GRAPHITE CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
GRAPHITE CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
GRAPHITE CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC |